Yuanqing Li Selected Research

Consciousness Disorders

1/2022	Toward Assessment of Sound Localization in Disorders of Consciousness Using a Hybrid Audiovisual Brain-Computer Interface.
1/2022	Brain-Computer Interfaces for Awareness Detection, Auxiliary Diagnosis, Prognosis, and Rehabilitation in Patients with Disorders of Consciousness.
1/2020	Prognosis for patients with cognitive motor dissociation identified by brain-computer interface.
1/2019	A Brain-Computer Interface Based on Three-Dimensional Stereo Stimuli for Assisting Clinical Object Recognition Assessment in Patients With Disorders of Consciousness.
10/2018	A gaze-independent audiovisual brain-computer Interface for detecting awareness of patients with disorders of consciousness.
8/2018	Visual Fixation Assessment in Patients with Disorders of Consciousness Based on Brain-Computer Interface.
1/2018	Emotion-Related Consciousness Detection in Patients With Disorders of Consciousness Through an EEG-Based BCI System.
1/2018	Assessment of Visual Pursuit in Patients With Disorders of Consciousness Based on a Brain-Computer Interface.
1/2017	Enhancing clinical communication assessments using an audiovisual BCI for patients with disorders of consciousness.
1/2016	An Auditory BCI System for Assisting CRS-R Behavioral Assessment in Patients with Disorders of Consciousness.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuanqing Li Research Topics

Disease

12	Consciousness Disorders 01/2022 - 10/2014
4	Neoplasms (Cancer) 12/2021 - 01/2021
3	Persistent Vegetative State (Vegetative State) 01/2020 - 12/2015
3	Albuminuria 02/2016 - 01/2013
2	Coma (Comas) 01/2020 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2016
2	Hypertension (High Blood Pressure) 01/2020 - 01/2019
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2013 - 01/2013
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2022
1	Fibrosis (Cirrhosis) 04/2022
1	Nephrotic Syndrome (Syndrome, Nephrotic) 04/2022
1	Proteinuria 04/2022
1	IGA Glomerulonephritis (IGA Nephropathy) 04/2022
1	Ovarian Neoplasms (Ovarian Cancer) 12/2021
1	Carcinogenesis 12/2021
1	Tinnitus 06/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021
1	Pulmonary Hypertension 12/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2020
1	Tremor (Tremors) 11/2020
1	Parkinson Disease (Parkinson's Disease) 11/2020
1	Ischemic Stroke 11/2020
1	Stroke (Strokes) 11/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Chronic Renal Insufficiency 01/2020
1	Obesity 01/2020
1	Vascular Diseases (Vascular Disease) 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2015
1	Cough 04/2015
1	Fatigue 04/2015
1	Type 2 Diabetes Mellitus (MODY) 01/2013
1	Atherosclerosis 01/2013
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2013
1	Hyperglycemia 01/2013

Drug/Important Bio-Agent (IBA)

5	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2018 - 01/2016
2	Histones (Histone)IBA 12/2021 - 01/2020
2	Lysine (L-Lysine)FDA Link 12/2021 - 01/2020
1	Antiviral Agents (Antivirals)IBA 04/2022
1	ledipasvirIBA 04/2022
1	Immunoglobulins (Immunoglobulin)IBA 04/2022
1	SofosbuvirIBA 04/2022
1	AcetylesteraseIBA 12/2021
1	Biological ProductsIBA 12/2021
1	ChromatinIBA 12/2021
1	EnzymesIBA 12/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2021
1	Cyclin-Dependent Kinase 9IBA 02/2021
1	Proteolysis Targeting ChimeraIBA 02/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 12/2020
1	LDL CholesterolIBA 11/2020
1	CholesterolIBA 11/2020
1	oxidized low density lipoproteinIBA 11/2020
1	SodiumIBA 01/2020
1	MethyltransferasesIBA 01/2020
1	SmokeIBA 01/2019
1	fasudil (AT 877)IBA 02/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	CreatinineIBA 01/2013
1	OccludinIBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	AlbuminsIBA 01/2013
1	Simvastatin (Zocor)FDA LinkGeneric 01/2013
1	mouse MIRN29 microRNAIBA 01/2013
1	MicroRNAs (MicroRNA)IBA 01/2013

Therapy/Procedure

9	Brain-Computer Interfaces 01/2022 - 10/2014
4	Therapeutics 04/2022 - 01/2016
1	Cholecystectomy 04/2022
1	Splenectomy 04/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2020
1	Neurofeedback 11/2020
1	Aftercare (After-Treatment) 04/2015
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2015